Latest Insider Transactions at Science 37 Holdings, Inc. (SNCE)
This section provides a real-time view of insider transactions for Science 37 Holdings, Inc. (SNCE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Science 37 Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Science 37 Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 12
2024
|
Thermo Fisher Scientific Inc. |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
1,737,980
-100.0%
|
$8,689,900
$5.75 P/Share
|
|
Mar 12
2024
|
Redmile Group, LLC |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
1,017,203
-100.0%
|
$5,086,015
$5.75 P/Share
|
|
Mar 12
2024
|
Robert C. Faulkner |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
26,791
-100.0%
|
$133,955
$5.75 P/Share
|
|
Mar 12
2024
|
David Coman Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
30,781
-100.0%
|
$153,905
$5.75 P/Share
|
|
Mar 12
2024
|
David Coman Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
53,834
-100.0%
|
$269,170
$5.75 P/Share
|
|
Mar 12
2024
|
John W Hubbard |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
2,050
-100.0%
|
$10,250
$5.75 P/Share
|
|
Mar 12
2024
|
Emily Rollins |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
2,050
-100.0%
|
$10,250
$5.75 P/Share
|
|
Mar 12
2024
|
Neil Tiwari |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
2,050
-100.0%
|
$10,250
$5.75 P/Share
|
|
Mar 12
2024
|
Paul Von Autenried |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
2,302
-100.0%
|
$11,510
$5.75 P/Share
|
|
Mar 12
2024
|
Christine A Pellizzari Chief Legal and HR Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
35,115
-100.0%
|
$175,575
$5.75 P/Share
|
|
Mar 12
2024
|
Christine A Pellizzari Chief Legal and HR Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
14,579
-100.0%
|
$72,895
$5.75 P/Share
|
|
Mar 12
2024
|
Mike Zaranek Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
22,212
-100.0%
|
$111,060
$5.75 P/Share
|
|
Mar 12
2024
|
Mike Zaranek Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
9,070
-100.0%
|
$45,350
$5.75 P/Share
|
|
Mar 12
2024
|
Darcy Forman Chief Delivery Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
24,644
-100.0%
|
$123,220
$5.75 P/Share
|
|
Mar 12
2024
|
Darcy Forman Chief Delivery Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
15,753
-100.0%
|
$78,765
$5.75 P/Share
|
|
Mar 12
2024
|
Jonathan Cotliar Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,864
-100.0%
|
$64,320
$5.75 P/Share
|
|
Mar 12
2024
|
Jonathan Cotliar Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
41,891
-100.0%
|
$209,455
$5.75 P/Share
|
|
Mar 12
2024
|
Michael Shipton Chief Commercial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
9,247
-100.0%
|
$46,235
$5.75 P/Share
|
|
Mar 10
2024
|
Michael Shipton Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,006
-24.53%
|
$15,030
$5.73 P/Share
|
|
Mar 10
2024
|
Michael Shipton Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,713
+41.56%
|
-
|
|
Oct 07
2023
|
Michael Shipton Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
29,201
-29.2%
|
$0
$0.41 P/Share
|
|
Oct 07
2023
|
Michael Shipton Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+50.0%
|
-
|
|
Aug 12
2023
|
David Coman Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
144,576
-7.87%
|
$0
$0.44 P/Share
|
|
Aug 12
2023
|
David Coman Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
495,122
+21.23%
|
-
|
|
Aug 12
2023
|
Mike Zaranek Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
74,813
-10.68%
|
$0
$0.44 P/Share
|
|
Aug 12
2023
|
Mike Zaranek Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
256,207
+26.78%
|
-
|
|
Aug 12
2023
|
Darcy Forman Chief Delivery Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
84,380
-9.46%
|
$0
$0.44 P/Share
|
|
Aug 12
2023
|
Darcy Forman Chief Delivery Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
288,972
+24.46%
|
-
|
|
Aug 12
2023
|
Christine A Pellizzari Chief Legal and HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
86,577
-8.04%
|
$0
$0.44 P/Share
|
|
Aug 12
2023
|
Christine A Pellizzari Chief Legal and HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
355,549
+24.83%
|
-
|
|
Aug 12
2023
|
Jonathan Cotliar Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
79,839
-6.8%
|
$0
$0.44 P/Share
|
|
Aug 12
2023
|
Jonathan Cotliar Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
230,882
+16.42%
|
-
|
|
May 19
2023
|
Christine A Pellizzari Chief Legal and HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,614
-0.77%
|
-
|
|
May 19
2023
|
Christine A Pellizzari Chief Legal and HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+2.24%
|
-
|
|
May 11
2023
|
Robert C. Faulkner |
BUY
Grant, award, or other acquisition
|
Direct |
494,853
+48.01%
|
$0
$0.25 P/Share
|
|
May 11
2023
|
Redmile Group, LLC |
BUY
Grant, award, or other acquisition
|
Indirect |
494,853
+2.37%
|
$0
$0.25 P/Share
|
|
May 11
2023
|
Neil Tiwari |
BUY
Exercise of conversion of derivative security
|
Direct |
40,983
+50.0%
|
-
|
|
May 11
2023
|
Emily Rollins |
BUY
Exercise of conversion of derivative security
|
Direct |
40,983
+50.0%
|
-
|
|
May 11
2023
|
John W Hubbard |
BUY
Exercise of conversion of derivative security
|
Direct |
40,983
+50.0%
|
-
|
|
May 11
2023
|
Paul Von Autenried |
BUY
Exercise of conversion of derivative security
|
Direct |
46,040
+50.0%
|
-
|
|
Apr 28
2023
|
Jonathan Cotliar Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
257,320
+21.42%
|
-
|
|
Apr 28
2023
|
Darcy Forman Chief Delivery Officer |
BUY
Grant, award, or other acquisition
|
Direct |
492,916
+44.96%
|
-
|
|
Apr 28
2023
|
Christine A Pellizzari Chief Legal and HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
702,332
+49.73%
|
-
|
|
Apr 28
2023
|
Mike Zaranek Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
444,283
+50.0%
|
-
|
|
Apr 28
2023
|
David Coman Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
615,650
+31.45%
|
-
|
|
Nov 17
2022
|
Christine A Pellizzari Chief Legal and HR Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$0
$0.81 P/Share
|
|
Jun 29
2022
|
Darcy Forman Chief Delivery Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
68,075
+38.13%
|
$0
$0.28 P/Share
|
|
Jun 13
2022
|
Redmile Group, LLC |
BUY
Other acquisition or disposition
|
Indirect |
6,472,228
+24.59%
|
$19,416,684
$3.38 P/Share
|
|
Jun 13
2022
|
Redmile Group, LLC |
SELL
Other acquisition or disposition
|
Indirect |
6,472,228
-24.59%
|
$19,416,684
$3.38 P/Share
|
|
May 23
2022
|
Robert C. Faulkner |
BUY
Grant, award, or other acquisition
|
Direct |
40,983
+50.0%
|
$122,949
$3.05 P/Share
|